Clinical Trial

18F-FAPI PET in Cancers of Unknown Primary Site

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the diagnostic efficacy, therapeutic assessment, prognostic analysis, and impact on clinical treatment decisions of 18F-FAPI PET/CT in patients with cancer of unknown primary.
Trial Details
NCT Number NCT07372963
Lead Sponsor First Affiliated Hospital of Zhejiang University
Conditions Cancer of Unknown Primary Site
Enrollment 120 participants
Start Date 2026-02-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-28